Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells

Journal of Pathology

Volumn 182, Issue 2, 1997, Pages 151-159

  Niedobitek, Gerald ^a,d   Agathanggelou, Angelo ^a   Herbst, Hermann ^b,e   Whitehead, Lucie ^a   Wright, Dennis H ^c   Young, Lawrence S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

EBV; Infectious mononucleosis; Virus latency; Virus replication

Indexed keywords

CELL NUCLEUS ANTIGEN; MEMBRANE PROTEIN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; INFECTION; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0030791517     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3     Document Type: Article

References (49)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 2nd edn. Philadelphia: Lippincott-Raven, 1996; 2397-2446.
2. Nilsson K, Klein G, Henle W, Henle G. The establishment of lymphoblastoid cell lines from adult and from foetal human lymphoid tissue and its dependence on EBV. Int J Cancer 1971; 8: 443-450.
3. Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumours. Lancet 1994; 343: 333-335.
4. Henle G, Henle W, Diehl V. Relation of a Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968; 59: 94-101.
5. Niedobitek G, Hamilton-Dutoit S, Herbst H, et al. Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum Pathol 1989; 20: 796-799.
6. Niedobitek G, Herbst H, Young LS, et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992; 79: 2520-2526.
7. Tosato G, Magrath I, Koski I, Dooley N, Blaese M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med 1979; 201: 1133-1137.
8. Lemon SM, Hutt LM, Shaw JE, Li J-LH, Pagano JS. Replication of EBV in epithelial cells during infectious mononucleosis. Nature 1977; 70: 268-270.
9. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984; 310: 1225-1230.
10. Greenspan JS, Greenspan D, Lennette ET, et al Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-association lesion. N Engl J Med 1985; 313: 1564-1571.
11. Niedobitek G, Young LS, Lau R, et al. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J Gen Virol 1991; 72: 3035-3046.
12. Thomas JA, Felix DH, Wray D, et al. Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am J Pathol 1991; 139: 1369-1380.
13. Allday MJ, Crawford DH. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet 1988; i: 855-857.
14. Gratama JW, Oosterveer MAP, Zwaan FE, et al. Eradication of Epstein Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci USA 1988; 85: 8693-8696.
15. Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB. The Epstein-Barr virus: host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy. Int J Cancer 1989; 43: 61-66.
16. Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus-carriers. Iny J Cancer 1989; 43: 67-71.
17. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995; 85: 744-750.
18. Weiss LM, Movahed LA. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am J Pathol 1989; 134: 651-659.
19. Deamant FD, Albujar PF, Chen YY, Weiss LM. Epstein-Barr virus distribution in nonneoplastic lymph nodes. Mod Pathol 1993; 6: 729-732.
20. Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993; 92: 1444-1450.
21. Kikuta H, Taguchi Y, Tomizawa K, et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333: 455-457.
22. Pallesen G, Hamilton-Dutoit SJ, Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv Cancer Res 1994; 62: 179-239.
23. Herbst H, Stein H, Niedobitek G. Epstein-Barr virus in CD30 + malignant lymphomas. Crit Rev Oncogenesis 1993; 4: 191-239.
24. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992; 140: 769-774.
25. Rowlands DC, Ito M, Mangham DC, et al. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br J Cancer 1993; 68: 1014-1019.
26. Prevot S, Neris J, Desaintmaur PP. Detection of Epstein-Barr virus in a hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient. Virchows Arch 1994; 425: 321-325.
27. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995; 332: 12-18.
28. Watry D, Hedrick JA, Siervo S, et al. Infection of human thymocytes by Epstein-Barr virus. J Exp Med 1991; 173: 971-980.
29. Jones K, Rivera C, Sgadari C, et al. Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 1995; 182: 1213-1221.
30. Rowe M, Lear A, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus (EBV) gene activation from EBNA1-positive latency in B lymphocytes. J Virol 1992; 66: 122-131.
31. Young L, Alfieri C, Hennessey K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989; 321: 1080-1085.
32. Hamilton-Dutoit SJ, Rea D, Raphael M, et al. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993; 143: 1072-1085.
33. Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177: 339-349.
34. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992; 66: 2689-2697.
35. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma. EMBO J 1987; 6: 2743-2751.
36. Niedobitek G, Agathanggelou A, Rowe M, et al. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 1995; 86: 659-665.
37. Falk K, Ernberg I, Sakthivel R, et al. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis. Int J Cancer 1990; 46: 976-984.
38. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol 1991; 165: 289-299.
39. Tierney RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994; 68: 7374-7385.
40. Foss HD, Herbst H, Hummel M, et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994; 83: 707-712.
41. Isaacson PG, Schmid C, Pan L, Wotherspoon AC, Wright DH. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternbere-like cells in acute infectious mononucleosis. J Pathol 1992; 167: 267-271.
42. Turley H, Jones M, Erber W, et al. VS38: a new monoclonal antibody detecting plasma cell differentiation in routine sections. J Clin Pathol 1994; 47: 418-422.
43. Chen F, Zou J-Z, Di Renzo L, et al. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 1995; 69: 3752-3758.
44. Reynolds DJ, Banks PM, Gulley ML. New characterisation of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. Am J Pathol 1995; 146: 379-388.
45. Alfieri C, Birkenbach M, Kieff E. Early events in Epstein-Barr virus infection of human lymphocytes-B. Virology 1991; 181: 595-608.
46. Robinson JE, Smith D, Niederman J. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis. J Exp Med 1981; 153: 235-244.
47. Rosen A, Gergley P, Jondal M, Klein G, Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 1977; 267: 52-54.
48. Prange E, Trautmann JC, Kreipe H, Radzun HJ, Parwaresch MR. Detection of Epstein-Barr virus in lymphoid tissues of patients with infectious mononudeosis by in situ hybridization. J Pathol 1992; 166: 113-119.
49. Crawford DH, Ando I. Epstein-Barr virus induction is associated with B-cell maturation. Immunology 1986; 59: 405-409.